Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?

Basit Öğe Kaydı
dc.contributor.authorKocatürk, Emek
dc.contributor.authorBülbül Başkan, Emel
dc.contributor.authorEngin, Betül Hacer
dc.contributor.authorÖzdemir, Mehmet Akif
dc.contributor.authorKüçük, Özlem Su
dc.contributor.authorCan, Pelin
dc.contributor.authorÖrnek, Seçil
dc.contributor.authorHasal, Eda
dc.contributor.authorAtakan, Nilgün
dc.date.accessioned2020-03-12T07:50:26Z
dc.date.available2020-03-12T07:50:26Z
dc.date.issued2019
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Academy of Allergy and Clinical Immunologyen_US
dc.identifier.citationKocatürk, E., Bülbül Başkan, E., Engin, B. H., Özdemir, M. A., Küçük, Ö. S., Can, P. ... Atakan, N. (2019). Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment? Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) içinde (484-485. ss.). Lisbon, Portugal, June 01-05, 2019.
dc.identifier.endpage485
dc.identifier.issn0105-4538
dc.identifier.issn1398-9995
dc.identifier.issueSupplement: 106
dc.identifier.startpage484
dc.identifier.urihttps://hdl.handle.net/20.500.12511/5029
dc.identifier.volume74
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofCongress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOmalizumab Versus
dc.subjectSpontaneous Urticaria
dc.subjectSpecific Patient
dc.titleOmalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?
dc.typeConference Object

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Bildiri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu